Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2025-12-24 @ 4:59 PM
NCT ID:
NCT00002450
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are HIV-positive.
* Have been on stable anti-HIV therapy for at least 8 weeks with no more than 4 anti-HIV drugs at the time of study entry.
* Have a viral load (level of HIV in the blood) between 400 and 10,000 copies/ml.
* Have good kidney function.
* Are 18 to 65 years old.
* Agree to use a barrier method of birth control (such as condoms) during the study and for 30 days after.
Exclusion Criteria
Patients will not be eligible for this study if they:
* Have a new AIDS-related illness diagnosed within 30 days of study entry.
* Have any other serious medical conditions, including kidney or bone disease, an active infection requiring antibiotics, or cancer (other than Kaposi's sarcoma or certain skin cancers).
* Have received a vaccine within 30 days of study entry.
* Are unable to take medications by mouth.
* Have ever taken tenofovir or adefovir dipivoxil.
* Have taken certain medications within 30 days of study entry, such as chemotherapy, corticosteroids, medications that affect the kidneys, treatment for Kaposi's sarcoma, or certain experimental drugs.
* Abuse alcohol or drugs.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00002450
Study Brief:
Protocol Section:
NCT00002450